Abbott Laboratories (ABL) Q3 2021 Earnings Report
DE:ABL Q3 2021 EPS Results
- Actual EPS
- EUR 1.25
- Consensus EPS
- EUR 0.85
- Beat/Miss
- Beat by +EUR 0.41
- One Year Ago EPS
- EUR 0.88
DE:ABL Q3 2021 Revenue Results
- Actual Revenue
- EUR 9.78B
- Expected Revenue
- EUR 8.56B
- Beat/Miss
- Beat by +EUR 1.22B
- YoY Revenue Growth
- +23.44%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 10/20/2021
- Time
- Before Open
- Conference Call
- Wednesday, October 20, 2021
DE:ABL Upcoming Earnings
Abbott Laboratories's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ABL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 27, 2027 | 2026 (Q4) | 1.47- | 1.34 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 1.271.27 | 1.16 | 9.23% (+0.11) | |
| Jul 16, 2026 | 2026 (Q2) | 1.141.17 | 1.13 | 3.97% (+0.04) | |
| Apr 16, 2026 | 2026 (Q1) | 1.031.03 | 0.98 | 5.50% (+0.05) | |
| Jan 22, 2026 | 2025 (Q4) | 1.341.34 | 1.2 | 11.94% (+0.14) | |
| Oct 15, 2025 | 2025 (Q3) | 1.171.16 | 1.08 | 7.44% (+0.08) | |
| Jul 17, 2025 | 2025 (Q2) | 1.121.13 | 1.02 | 10.53% (+0.11) | |
| Apr 16, 2025 | 2025 (Q1) | 0.960.98 | 0.88 | 11.22% (+0.10) | |
| Jan 22, 2025 | 2024 (Q4) | 1.201.20 | 1.07 | 12.61% (+0.13) | |
| Oct 16, 2024 | 2024 (Q3) | 1.081.08 | 1.02 | 6.14% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
